Does ±3,4-methylenedioxymethamphetamine (ecstasy) induce subjective feelings of social connection in humans? A multilevel meta-analysis
This multilevel meta-analysis of 27 placebo-controlled studies (54 effect sizes, N = 592) found that MDMA produces a moderate-to-large increase in self-reported sociability-related feelings (d = 0.86, 95% CI 0.68–1.04; r = .39). The authors conclude this effect size suggests MDMA could meaningfully enhance social connection in both social and clinical contexts and discuss possible mechanisms and directions for future research.
Abstract
3,4-Methylenedioxymethamphetamine (MDMA) is a psychostimulant known for producing positive subjective effects and for enhancing social functioning and social connection in both clinical and recreational settings. Over the past two decades, scientists have begun to study the psychological effects of MDMA through rigorous placebo-controlled experimental work. However, most existing studies have small Ns, and the average sizes of the reported effects are unknown, creating uncertainty about the impact of these findings. The goal of the present study was to quantify the strength of MDMA’s effects on self-reported social connection by aggregating sociability-related outcomes across multiple placebo-controlled studies. To this end, we conducted a multilevel meta-analysis based on 27 studies, 54 effect sizes, and a total of 592 participants. The results revealed a moderate-to-large effect (d = 0.86; 95% CI [0.68, 1.04]; r = .39; 95% CI [.32, .46]) of MDMA on self-reported sociability-related outcomes (e.g., feeling loving, talkative, and friendly). Given the magnitude of its effect on felt sociability, we propose that MDMA may have powerful implications for a variety of social contexts and for clinical settings, in particular. Finally, we discuss potential mechanisms underlying the relationship between MDMA and sociability-related feelings, as well as future directions for experimental work in this area.
Research Summary of 'Does ±3,4-methylenedioxymethamphetamine (ecstasy) induce subjective feelings of social connection in humans? A multilevel meta-analysis'
Introduction
Regan and colleagues frame MDMA (ecstasy) as a psychostimulant historically associated with energising, euphoric and connecting effects, and note its renewed therapeutic interest, particularly in Phase II trials for treatment-resistant PTSD. Earlier experimental work has reported increases in self-reported feelings such as lovingness, friendliness and talkativeness after MDMA, but most individual studies have small sample sizes and there has been no quantitative synthesis to establish the average magnitude of these subjective sociability effects. This paper aims to fill that gap by conducting a multilevel meta-analysis of placebo-controlled human experiments to estimate the overall effect size of MDMA on self-reported sociability-related outcomes. The investigators also plan meta-regressions to explore moderators, specifically MDMA dose and the type of sociability measure used (for example, feeling talkative versus friendly).
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typemeta
- Journal
- Compound
- Topic
- Author
- APA Citation
Regan, A., Margolis, S., de Wit, H., & Lyubomirsky, S. (2021). Does ±3,4-methylenedioxymethamphetamine (ecstasy) induce subjective feelings of social connection in humans? A multilevel meta-analysis. PLOS ONE, 16(10), e0258849. https://doi.org/10.1371/journal.pone.0258849
References (26)
Papers cited by this study that are also in Blossom
Feduccia, A. A., Mithoefer, M. C. · Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018)
Jerome, L., Feduccia, A. A., Wang, J. B. et al. · Psychopharmacology (2020)
Bershad, A. K., Miller, M. A., Baggot, M. J. et al. · Journal of Psychopharmacology (2016)
Kamilar-Britt, P., Bedi, G. · Neuroscience and Biobehavioral Reviews (2015)
Van Wel, J. H. P., Kuypers, K. P. C., Theunissen, E. L. et al. · PLOS ONE (2012)
Bedi, G., Hyman, D., De Wit, H. · Biological Psychiatry (2010)
Hysek, C. M., Fink, A., Simmler, L. D. et al. · Journal of Clinical Psychopharmacology (2013)
Dolder, P. C., Müller, F., Schmid, Y. et al. · Psychopharmacology (2017)
Bershad, A. K., Mayo, L. M., Van Hedger, K. et al. · Neuropsychopharmacology (2019)
Doss, M. K., Weafer, J. J., Gallo, D. A. et al. · Neuropsychopharmacology (2017)
Show all 26 referencesShow fewer
Dumont, G., Sweep, F., van der Steen, R. et al. · Social Neuroscience (2009)
Frye, C. G., Wardle, M. C., Norman, G. J. et al. · Pharmacology Biochemistry and Behavior (2014)
Holze, F., Vizeli, P., Müller, F. et al. · Neuropsychopharmacology (2019)
´dric, C., Hysek, M., Schmid, Y. et al. · Social Cognitive and Affective Neuroscience (2013)
Kirkpatrick, M. G., Francis, S. M., Lee, R. et al. · Psychoneuroendocrinology (2014)
Kirkpatrick, M. G., Lee, R., Wardle, M. C. et al. · Neuropsychopharmacology (2014)
Kuypers, K. P. C., Dolder, P. C., Ramaekers, J. G. et al. · Journal of Psychopharmacology (2017)
Wardle, M. C., De Wit, H. · Psychopharmacology (2014)
Studerus, E., Gamma, A., Kometer, M. et al. · PLOS ONE (2012)
Danforth, A. L., Struble, C., Yazar-Klosinski, B. et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016)
Greer, G. R. · Journal of Psychoactive Drugs (1986)
Hibicke, M., Gobbi, G. · Journal of Neuroscience (2020)
Danforth, A. L., Grob, C. S., Struble, C. et al. · Psychopharmacology (2018)
Sessa, B. · Neuropharmacology (2017)
Heifets, B. D., Malenka, R. C. · Cell (2016)
Walsh, J. J., Llorach, P., Cardozo Pinto, D. F. et al. · Neuropsychopharmacology (2021)
Cited By (5)
Papers in Blossom that reference this study
Martinez, R. L., Radošić, N., Molla, H. et al. · Journal of Psychopharmacology (2025)
Elmer, T., Vannoy, T. K., Studerus, E. et al. · Scientific Reports (2024)
Neubert, J. J., Anderson, K., Mason, N. L. · Psyarxiv (2023)
Ponomarenko, P., Seragnoli, F., Calder, A. et al. · Journal of Psychopharmacology (2023)
Jones, G. M., Lipson, J., Wang, E. · Scientific Reports (2023)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.